Enzastaurin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Completed · Phase 2
Conditions studied: Ovarian Cancer, Primary Peritoneal Cavity Cancer
In brief
RATIONALE: Enzastaurin may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor. PURPOSE: This phase II trial is studying how well enzastaurin works in treating patients with persistent or recurrent ovarian epithelial cancer or primary peritoneal cancer.
Key facts
- Study ID
- NCT00407758
- Run by
- Gynecologic Oncology Group
- People needed
- 28
- Starts
- 2006-11-01
- Last updated by the study team
- 2019-03-20
Who can join
Age: 18 and older, up to 120. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Jonsson Comprehensive Cancer Center at UCLA — Los Angeles, California, United States
- Rush University Medical Center — Chicago, Illinois, United States
- Decatur Memorial Hospital Cancer Care Institute — Decatur, Illinois, United States
- Evanston Northwestern Healthcare - Evanston Hospital — Evanston, Illinois, United States
- Hinsdale Hematology Oncology Associates — Hinsdale, Illinois, United States
- CCOP - Carle Cancer Center — Urbana, Illinois, United States
- St. Vincent Indianapolis Hospital — Indianapolis, Indiana, United States
- CCOP - Grand Rapids — Grand Rapids, Michigan, United States
- Hulston Cancer Center at Cox Medical Center South — Springfield, Missouri, United States
- Methodist Estabrook Cancer Center — Omaha, Nebraska, United States
- Blumenthal Cancer Center at Carolinas Medical Center — Charlotte, North Carolina, United States
- Oklahoma University Cancer Institute — Oklahoma City, Oklahoma, United States
- Rosenfeld Cancer Center at Abington Memorial Hospital — Abington, Pennsylvania, United States
- Fox Chase Cancer Center - Philadelphia — Philadelphia, Pennsylvania, United States
- McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center — Reading, Pennsylvania, United States
- University Cancer Center at University of Washington Medical Center — Seattle, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.